The report analyzes and forecasts the Alzheimer’s drugs market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of Alzheimer’s drugs, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Alzheimer’s drugs companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Alzheimer’s drugs upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of Alzheimer’s drugs and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Alzheimer’s drugs market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Alzheimer’s drugs market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Alzheimer’s drugs market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Competitive Dynamics
The report also profiles major key players in the Alzheimer’s drugs market based on various attributes such as company overview, product portfolio, financial overview, business strategies, recent developments and company SWOT analysis. Major players operating in the Alzheimer’s drug market included in this report are Allergan plc, Novartis AG, Eisai Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited, Ono Pharmaceutical Co Ltd, Merz Holding GmbH & Co KG, and Johnson & Johnson.
Global Alzheimer’s Drugs Market is segmented as below:
Global Alzheimer’s Drug Market, by Drug Class
Global Alzheimer’s Drug Market, by Distribution Channel
Global Alzheimer’s Drug Market, by Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Chapter 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Chapter 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Chapter 3 Executive Summary
3.1 Alzheimer’s Drugs Market Snapshot, 2018
3.2 Alzheimer’s Drugs Market: Opportunity Map
Chapter 4 Market Overview
4.1 Introduction
4.2 Global Alzheimer’s Drugs Market Size (US$ Mn) Forecast, 2017–2026
4.3 Alzheimer’s Drugs Market Outlook
4.4 Key Industry Events
Chapter 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.2.1 Increasing global prevalence of Alzheimer’s
5.2.2 Improvising regulatory scenario
5.2.3 Increasing government funding
5.2.4 Entry of novel symptomatic therapies
5.2.5 Growing social awareness of the disease
5.3 Restraints
5.3.1 Alzheimer’s drug failure rate at 99%
5.3.2 Multifactorial etiology and complex pathophysiology of the disease
5.3.3 High level of comorbidity occurring in the elderly population
5.3.4 Expanding diagnostic capability
5.3.5 Increasing cost for Alzheimer’s drug development
5.4 Opportunities
5.4.1 Reduce the time and risk of AD drug development through an improvement in trial design
5.4.2 Improving clinical outcomes
5.5 Trends
5.5.1 Development of compounds acting on the main stages of the pathogenesis of the disease (disease-modifying agents
5.5.2 Focused design of multi targeted drugs acting on multiple molecular targets involved in the pathogenesis of the disease
5.6 Porter’s Five Forces Analysis
5.7 PEST Analysis
5.8 Pipeline Analysis
5.9 Global Prevalence & Incidence
5.10 Biomarkers Analysis
5.11 Most Promising Molecules
Chapter 6 Alzheimer’s Drugs Market Analysis by Drug Class
6.1 Key Findings
6.2 Introduction
6.3 Global Alzheimer’s Drugs Market Value Share Analysis, by Drug Class
6.4 Global Alzheimer’s Drugs Market Forecast, by Drug Class
6.5 Global Alzheimer’s Drugs Market Analysis, by Drug Class
6.6 Global Alzheimer’s Drugs Market Attractiveness Analysis, by Drug Class
6.7 Key Trends
Chapter 7 Alzheimer’s Drugs Market Analysis, by Distribution Channel
7.1 Key Findings
7.2 Introduction
7.3 Global Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel
7.4 Global Alzheimer’s Drugs Market Forecast, by Distribution Channel
7.5 Global Alzheimer’s Drugs Market Analysis, by Distribution Channel
7.6 Global Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel
7.7 Key Trends
Chapter 8 Alzheimer’s Drugs Market Analysis by Region
8.1 Global Alzheimer’s Drugs Market Snapshot, by Country
8.2 Global Alzheimer’s Drugs Market Value Share Analysis, by Region
8.3 Global Alzheimer’s Drugs Market Forecast, by Region
8.4 Global Alzheimer’s Drugs Market Attractiveness, by Region
Chapter 9 North America Alzheimer’s Drugs Market Analysis
9.1 Key Findings
9.2 North America Alzheimer’s Drugs Market Overview
9.3 North America Alzheimer’s Drugs Market Value Share Analysis, by Drug Class
9.4 North America Alzheimer’s Drugs Market Forecast, by Drug Class
9.5 North America Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel
9.6 North America Alzheimer’s Drugs Market Forecast, by Distribution Channel
9.7 North America Alzheimer’s Drugs Market Value Share Analysis, by Country
9.8 North America Alzheimer’s Drugs Market Forecast, by Country
9.9 North America Alzheimer’s Drugs Market Attractiveness Analysis
9.10 Market Trends
Chapter 10 Europe Alzheimer’s Drugs Market Analysis
10.1 Key Findings
10.2 Europe Alzheimer’s Drugs Market Overview
10.3 Europe Alzheimer’s Drugs Market Value Share Analysis, by Drug Class
10.4 Europe Alzheimer’s Drugs Market Forecast, by Drug Class
10.5 Europe Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel
10.6 Europe Alzheimer’s Drugs Market Forecast, by Distribution Channel
10.7 Europe Alzheimer’s Drugs Market Value Share Analysis, by Country
10.8 Europe Alzheimer’s Drugs Market Forecast, by Country
10.9 Europe Alzheimer’s Drugs Market Attractiveness Analysis
10.10 Market Trends
Chapter 11 Asia Pacific Alzheimer’s Drugs Market Analysis
11.1 Key Findings
11.2 Asia Pacific Alzheimer’s Drugs Market Overview
11.3 Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Drug Class
11.4 Asia Pacific Alzheimer’s Drugs Market Forecast, by Drug Class
11.5 Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel
11.6 Asia Pacific Alzheimer’s Drugs Market Forecast, by Distribution Channel
11.7 Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Country
11.8 Asia Pacific Alzheimer’s Drugs Market Forecast, by Country
11.9 Asia Pacific Alzheimer’s Drugs Market Attractiveness Analysis
11.10 Market Trends
Chapter 12 Latin America Alzheimer’s Drugs Market Analysis
12.1 Key Findings
12.2 Latin America Alzheimer’s Drugs Market Overview
12.3 Latin America Alzheimer’s Drugs Market Value Share Analysis, by Drug Class
12.4 Latin America Alzheimer’s Drugs Market Forecast, by Drug Class
12.5 Latin America Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel
12.6 Latin America Alzheimer’s Drugs Market Forecast, by Distribution Channel
12.7 Latin America Alzheimer’s Drugs Market Value Share Analysis, by Country
12.8 Latin America Alzheimer’s Drugs Market Forecast, by Country
12.9 Latin America Alzheimer’s Drugs Market Attractiveness Analysis
12.10 Market Trends
Chapter 13 Middle East and Africa (MEA) Alzheimer’s Drugs Market Analysis
13.1 Key Findings
13.2 Middle East and Africa Alzheimer’s Drugs Market Overview
13.3 Middle East and Africa Alzheimer’s Drugs Market Value Share Analysis, by Drug Class
13.4 Middle East and Africa Alzheimer’s Drugs Market Forecast, by Drug Class
13.5 Middle East and Africa Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel
13.6 Middle East and Africa Alzheimer’s Drugs Market Forecast, by Distribution Channel
13.7 Middle East and Africa Alzheimer’s Drugs Market Value Share Analysis, by Country
13.8 Middle East and Africa Alzheimer’s Drugs Market Forecast, by Country
13.9 Middle East and Africa Alzheimer’s Drugs Market Attractiveness Analysis
13.10 Market Trends
Chapter 14 Company Profiles
14.1 Alzheimer’s Market Share Analysis By Company
14.2 Competition Matrix
14.3 Company Profiles
14.3.1 Allergan plc
14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.1.4 Strategic Overview
14.3.2 Novartis AG
14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.2.4 Strategic Overview
14.3.3 Eisai Co Ltd
14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.3.4 Strategic Overview
14.3.4 Johnson & Johnson
14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.4.4 Strategic Overview
14.3.5 Daiichi Sankyo Company Limited
14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.5.4 Strategic Overview
14.3.6 Ono Pharmaceutical Co Ltd
14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.6.4 Strategic Overview
14.3.7 H Lundbeck A/S
14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.7.4 Strategic Overview
14.3.8 Merz Holding GmbH & Co KG
14.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.8.4 Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers